These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 23145004)

  • 1. Clinical value of prognosis gene expression signatures in colorectal cancer: a systematic review.
    Sanz-Pamplona R; Berenguer A; Cordero D; Riccadonna S; Solé X; Crous-Bou M; Guinó E; Sanjuan X; Biondo S; Soriano A; Jurman G; Capella G; Furlanello C; Moreno V
    PLoS One; 2012; 7(11):e48877. PubMed ID: 23145004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A network-based predictive gene expression signature for recurrence risks in stage II colorectal cancer.
    Yang WJ; Wang HB; Wang WD; Bai PY; Lu HX; Sun CH; Liu ZS; Guan DK; Yang GW; Zhang GL
    Cancer Med; 2020 Jan; 9(1):179-193. PubMed ID: 31724326
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis.
    Zhuang Y; Wang H; Jiang D; Li Y; Feng L; Tian C; Pu M; Wang X; Zhang J; Hu Y; Liu P
    BMC Cancer; 2021 Apr; 21(1):380. PubMed ID: 33836681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A network-based gene expression signature informs prognosis and treatment for colorectal cancer patients.
    Shi M; Beauchamp RD; Zhang B
    PLoS One; 2012; 7(7):e41292. PubMed ID: 22844451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ColoGuideEx: a robust gene classifier specific for stage II colorectal cancer prognosis.
    Agesen TH; Sveen A; Merok MA; Lind GE; Nesbakken A; Skotheim RI; Lothe RA
    Gut; 2012 Nov; 61(11):1560-7. PubMed ID: 22213796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Construction of Combinatory Cancer Hallmark-Based Gene Signature Sets to Predict Recurrence and Chemotherapy Benefit in Stage II Colorectal Cancer.
    Gao S; Tibiche C; Zou J; Zaman N; Trifiro M; O'Connor-McCourt M; Wang E
    JAMA Oncol; 2016 Jan; 2(1):37-45. PubMed ID: 26502222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A molecular signature for the prediction of recurrence in colorectal cancer.
    Wang L; Shen X; Wang Z; Xiao X; Wei P; Wang Q; Ren F; Wang Y; Liu Z; Sheng W; Huang W; Zhou X; Du X
    Mol Cancer; 2015 Feb; 14(1):22. PubMed ID: 25645394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A formalin-fixed paraffin-embedded (FFPE)-based prognostic signature to predict metastasis in clinically low risk stage I/II microsatellite stable colorectal cancer.
    Low YS; Blöcker C; McPherson JR; Tang SA; Cheng YY; Wong JYS; Chua C; Lim TKH; Tang CL; Chew MH; Tan P; Tan IB; Rozen SG; Cheah PY
    Cancer Lett; 2017 Sep; 403():13-20. PubMed ID: 28624625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide Discovery and Identification of a Novel miRNA Signature for Recurrence Prediction in Stage II and III Colorectal Cancer.
    Kandimalla R; Gao F; Matsuyama T; Ishikawa T; Uetake H; Takahashi N; Yamada Y; Becerra C; Kopetz S; Wang X; Goel A
    Clin Cancer Res; 2018 Aug; 24(16):3867-3877. PubMed ID: 29514841
    [No Abstract]   [Full Text] [Related]  

  • 10. Lymphocytic infiltration in stage II microsatellite stable colorectal tumors: A retrospective prognosis biomarker analysis.
    Sanz-Pamplona R; Melas M; Maoz A; Schmit SL; Rennert H; Lejbkowicz F; Greenson JK; Sanjuan X; Lopez-Zambrano M; Alonso MH; Qu C; McDonnell KJ; Idos GE; Vignali M; Emerson R; Fields P; Guinó E; Santos C; Salazar R; Robins HS; Rennert G; Gruber SB; Moreno V
    PLoS Med; 2020 Sep; 17(9):e1003292. PubMed ID: 32970670
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune-related gene signature in predicting prognosis of early-stage colorectal cancer patients.
    Ke J; Liu XH; Jiang XF; He Z; Xiao J; Zheng B; Chen YF; Cai ZR; Zheng XB; Zou YF; Lan P; Wu XJ; Gao F
    Eur J Surg Oncol; 2020 Oct; 46(10 Pt B):e62-e70. PubMed ID: 32863096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transcriptional signatures for coupled predictions of stage II and III colorectal cancer metastasis and fluorouracil-based adjuvant chemotherapy benefit.
    Song K; Guo Y; Wang X; Cai H; Zheng W; Li N; Song X; Ao L; Guo Z; Zhao W
    FASEB J; 2019 Jan; 33(1):151-162. PubMed ID: 29957060
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene signatures of estrogen and progesterone receptor pathways predict the prognosis of colorectal cancer.
    Liu D
    FEBS J; 2016 Aug; 283(16):3115-33. PubMed ID: 27376509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A rank-based transcriptional signature for predicting relapse risk of stage II colorectal cancer identified with proper data sources.
    Zhao W; Chen B; Guo X; Wang R; Chang Z; Dong Y; Song K; Wang W; Qi L; Gu Y; Wang C; Yang D; Guo Z
    Oncotarget; 2016 Apr; 7(14):19060-71. PubMed ID: 26967049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Composite Gene Expression Signature Optimizes Prediction of Colorectal Cancer Metastasis and Outcome.
    Schell MJ; Yang M; Missiaglia E; Delorenzi M; Soneson C; Yue B; Nebozhyn MV; Loboda A; Bloom G; Yeatman TJ
    Clin Cancer Res; 2016 Feb; 22(3):734-45. PubMed ID: 26446941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of colorectal cancers and extraction of discriminator gene signatures for personalized prediction of prognosis.
    Miyake M; Takemasa I; Matoba R; Tanino M; Niijima S; Ikeda M; Yamamoto H; Sekimoto M; Kuhara S; Okayama T; Monden M; Matsubara K; Mori M
    Int J Oncol; 2011 Oct; 39(4):781-9. PubMed ID: 21701771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene expression profiles as predictors of poor outcomes in stage II colorectal cancer: A systematic review and meta-analysis.
    Lu AT; Salpeter SR; Reeve AE; Eschrich S; Johnston PG; Barrier AJ; Bertucci F; Buckley NS; Salpeter EE; Lin AY
    Clin Colorectal Cancer; 2009 Oct; 8(4):207-14. PubMed ID: 19822511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRC-113 gene expression signature for predicting prognosis in patients with colorectal cancer.
    Nguyen MN; Choi TG; Nguyen DT; Kim JH; Jo YH; Shahid M; Akter S; Aryal SN; Yoo JY; Ahn YJ; Cho KM; Lee JS; Choe W; Kang I; Ha J; Kim SS
    Oncotarget; 2015 Oct; 6(31):31674-92. PubMed ID: 26397224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a lipogenic genes panel for diagnosis and recurrence of colorectal cancer.
    Gharib E; Nasrinasrabadi P; Zali MR
    PLoS One; 2020; 15(3):e0229864. PubMed ID: 32155177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concomitant dysregulation of the estrogen receptor and BRAF/MEK signaling pathways is common in colorectal cancer and predicts a worse prognosis.
    Liu D
    Cell Oncol (Dordr); 2019 Apr; 42(2):197-209. PubMed ID: 30645729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.